Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicholson B. Perkins
Observed names:
Nicholson B Perkins,
Nicholson B. Perkins III,
Nicholson Perkins
Institution:
Methodist University Hospital
Observed institutions:
Henry Ford Health,
University of Tennessee Health Science Center,
St Vincent Hospital,
Henry Ford Hospital,
Methodist University Hospital
ORCID:
0000-0002-3650-3959
Observed ORCID:
0000-0002-3650-3959
OpenAlex ID:
A5088008458
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii
2022
·
Sara Alosaimy
, Taylor Morrisette
, et al.
·
Microbiology Spectrum
·
59
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022
2023
·
Ashlan J. Kunz Coyne
, Sara Alosaimy
, et al.
·
Microbiology Spectrum
·
44
WNT5B drives osteosarcoma stemness, chemoresistance and metastasis
2024
·
Rachel S. Perkins
, Glenn Murray
, et al.
·
Clinical and Translational Medicine
·
33
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections
2025
·
Mohammed Al Musawa
, Ashlan J. Kunz Coyne
, et al.
·
Infectious Diseases and Therapy
·
13
PDF
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomes
2025
·
Ashlan J. Kunz Coyne
, Sara Alosaimy
, et al.
·
Microbiology Spectrum
·
11
PDF
Time to defervescence evaluation for extended‐ vs. standard‐infusion cefepime in patients with acute leukemia and febrile neutropenia
2022
·
Robert Crawford
, Nicholson B. Perkins
, et al.
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
·
10
Residual Infusion Performance Evaluation (RIPE): A Single-Center Evaluation of Residual Volume Post-Intravenous Eravacycline Infusion
2023
·
Alysa J. Baumann
, Kerry O. Cleveland
, et al.
·
Pharmacy
·
6
PDF
Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysis
2025
·
Sean R. Van Helden
, Ashlan J. Kunz Coyne
, et al.
·
BMC Infectious Diseases
·
3
PDF
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving Enterobacterales
2026
·
Sean R. Van Helden
, Ashlan J. Kunz Coyne
, et al.
·
Microbiology Spectrum
·
2
1304. Antimicrobial Management of Stenotrophomonas maltophilia Pneumonia: Does TMP-SMX Dose Affect Treatment Failure?
2021
·
J Myles Keck
, Nicholson Perkins
, et al.
·
Open Forum Infectious Diseases
·
1
Correction: Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections
2025
·
Mohammed Al Musawa
, Ashlan J. Kunz Coyne
, et al.
·
Infectious Diseases and Therapy
PDF
2677. Evaluation of Expedited Partner Therapy Prescribing in an Urban Emergency Department
2023
·
Nicholson B Perkins
, William Campillo Terrazas
, et al.
·
Open Forum Infectious Diseases
PDF
1017. Residual Infusion Performance Evaluation (RIPE): A Single-Center Evaluation of Residual Volume Post-Intravenous Eravacycline Infusion
2022
·
Alysa J Baumann
, Kerry O Cleveland
, et al.
·
Open Forum Infectious Diseases
1288. Evaluation of Predictors for Clinical Success in Patients Treated with Eravacycline for Various Infections
2021
·
Sara Alosaimy
, Taylor Morrisette
, et al.
·
Open Forum Infectious Diseases
1577. Real-World, Multicenter Experience with Eravacycline for Various Infections
2020
·
Sara Alosaimy
, Abdalhamid M Lagnf
, et al.
·
Open Forum Infectious Diseases
Show more works
View as search
Works count:
15
Citation count:
178
H-index:
6
I10-index:
6
Year
Topic
Type